When Tom Bumol, Ph.D., moved into his new office at the Allen Institute, he gave…
sciencecityMarch 1, 2019
Seattle biotech company Blaze Bioscience has raised $5 million in funding as it pursues a pivotal trial…
sciencecityFebruary 28, 2019
Bacteria lodged deep in Ella Balasa’s lungs were impervious to most antibiotics. At 26, gasping for…
sciencecityFebruary 28, 2019
After 25 years of success in infectious disease research and development, IDRI is poised to…
sciencecityFebruary 28, 2019
Actor Michael J. Fox has drawn national attention to the tremors and difficulties with balancing…
sciencecityFebruary 27, 2019
The first clinical study investigating the use of the direct oral anticoagulant, rivaroxaban, to prevent blood…
sciencecityFebruary 26, 2019
Merck, one of the world’s largest drugmakers, agreed to buy Seattle-based biotechnology company Immune Design for $300 million in…
sciencecityFebruary 25, 2019
In an effort to produce vaccines where they are needed most, IDRI (Infectious Disease Research…
sciencecityFebruary 25, 2019
